Design of core–shell mesoporous silica nanospheres as a delivery system of nimesulide – physicochemical and biological characterization
References
- Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., Manzano, M., Engineering mesoporous silica nanoparticles for drug delivery: Where are we after two decades?, Chem. Soc. Rev., 2022; 51: 13. 10.1039/D1CS00659B.
- Asefa, T., Tao, Z., Biocompatibility of mesoporous silica nanoparticles, Chem. Res. Toxicol., 2012; 25(11): 2265–2284. 10.1021/tx300166u.
- Feng, Y., Liao, Z., Li, M., Zhang, H., Li, T., Qin, X., et al., Mesoporous silica nanoparticles-based nanoplatforms: Basic construction, current state, and emerging applications in anticancer therapeutics, Adv. Healthc. Mater., 2023; 12: e2201884. 10.1002/adhm.202201884.
- Liu, J., Liu, J., Wang, Y., Chen, F., He, Y., Xie, X., et al., Bioactive mesoporous silica materials-assisted cancer immunotherapy, Biomaterials, 2025; 315: 122919. 10.1016/j.biomaterials.2024.122919.
- Wagner, J., Gößl, D., Ustyanovska, N., Xiong, M., Hauser, D., Zhuzhgova, O., et al., Mesoporous silica nanoparticles as pH-responsive carrier for the immune-activating drug resiquimod enhance the local immune response in mice, ACS Nano, 2021; 15: 4450–4466. 10.1021/acsnano.0c08384.
- Zhang, W., Liu, H., Qiu, X., Zuo, F., Wang, B., Mesoporous silica nanoparticles as a drug delivery mechanism, Open Life Sci., 2024; 19(1): 20220867. 10.1515/biol-2022-0867.
- Moritz, M., Geszke-Moritz, M., Mesoporous materials as elements of modern drug delivery systems for anti-inflammatory agents: A review of recent achievements, Pharmaceutics, 2022; 14(8): 1542. 10.3390/pharmaceutics14081542.
- Atiyah, N. A., Albayati, T. M., Atiya, M. A., Functionalization of mesoporous MCM-41 for the delivery of curcumin as an anti-inflammatory therapy, Adv. Powder Technol., 2022; 33: 103417. 10.1016/j.apt.2021.103417.
- Yang, L., Yan, N., Li, J., Contribution of molecular-modified biomimetic mesoporous silica xerogel in delivering nimesulide with superior anti-inflammatory efficacy, J. Mater. Sci. Mater. Med., 2025; 36(1): 98. 10.1007/s10856-025-06952-w.
- Gou, K., Wang, Y., Guo, X., Wang, Y., Bian, Y., Zhao, H., et al., Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs, Acta Biomater., 2021; 134: 576–592. 10.1016/j.actbio.2021.07.023.
- Vunnam, N., Young, C. M., Liao, E. E., Lo, C. H., Huber, E., Been, M., Thomas, D. D., Sachs, J. N., Nimesulide, a COX-2 inhibitor, sensitizes pancreatic cancer cells to TRAIL-induced apoptosis by promoting DR5 clustering, Cancer Biol. Ther., 2023; 24(1): 2176692. 10.1080/15384047.2023.2176692.
- de Almeida, A. C., Ferreira, P. O., Porto, M. V., et al., Novel nimesulide multicomponent solid forms: Screening, synthesis, thermoanalytical study and characterization, J. Therm. Anal. Calorim., 2025; 150: 6885–6897. 10.1007/s10973-024-13189-2.
- National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
- Bouma, M. E., Rogier, E., Verthier, N., Labarre, C., Feldmann, G., Further cellular investigation of the human hepatoblastoma-derived cell line HepG2: Morphology and immunocytochemical studies of hepatic-secreted proteins, In Vitro Cell. Dev. Biol., 1989; 25: 267–275.
- Krithika, R., Mohankumar, R., Verma, R. J., Shrivastav, P. S., Mohamad, I. L., Gunasekaran, P., Narasimhan, S., Isolation, characterization and antioxidative effect of phyllanthin against CCl4-induced toxicity in HepG2 cell line, Chem. Biol. Interact., 2009; 181: 351–358. 10.1016/j.cbi.2009.06.014.
- Thommes, M., Kaneko, K., Neimark, A. V., Olivier, J. P., Rodriguez-Reinoso, F., Rouquerol, J., Sing, K. S., Physisorption of gases, with special reference to the evaluation of surface area and pore size distribution (IUPAC Technical Report), Pure Appl. Chem., 2015; 87(9–10): 1051–1069. 10.1515/pac-2014-1117.
- Riddick TM., Control of colloid stability through zeta potential., Wynnewood, PA, USA: Livingston Publishing Company; 1968.
- Ashour, M. M., Mabrouk, M., Soliman, I. E., Beherei, H. H., Tohamy, K. M., Mesoporous silica nanoparticles prepared by different methods for biomedical applications: Comparative study, IET Nanobiotechnol., 2021; 15(3): 291–300. 10.1049/nbt2.12023.
- Di Martino, P., Censi, R., Barthélémy, C., Gobetto, R., Joiris, E., Masic, A., Odou, P., Martelli, S., Characterization and compaction behaviour of nimesulide crystal forms, Int. J. Pharm., 2007; 342(1–2): 137–144. 10.1016/j.ijpharm.2007.05.009.
- Vallet-Regí, M., Rámila, A., Real, A.D., Pérez-Pariente, J., A new property of MCM-41: Drug delivery system, Chem. Mater., 2001; 13: 308–311. 10.1021/cm0011559.
- Bharti, C., Nagaich, U., Pal, A.K., Gulati, N., Mesoporous silica nanoparticles in target drug delivery system: A review, Int. J. Pharm. Investig., 2015; 5(3): 124–133. 10.4103/2230-973X.160844.
- Moghddam, S.M.M., Ahad, A., Aqil, M., Imam, S.S., Sultana, Y., Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box–Behnken design approach, Artif. Cells Nanomed. Biotechnol., 2017; 45(3): 617–624. 10.3109/21691401.2016.1167699.
- Farooqi, I.R., Raza, M., Zeenat, Zahid, F., Islam, Z., Asghar, M., Mesoporous silica nanocarriers for enhanced solubility and bioavailability of hydrophobic anticancer drugs, Indus J. Biosci. Res., 2025; 3(8): 366–373. 10.70749/ijbr.v3i8.2177
DOI: https://doi.org/10.2478/pjct-2026-0007 | Journal eISSN: 3072-0389 (formerly 1899-4741) | Journal ISSN: 1509-8117
Language: English
Page range: 102 - 114
Submitted on: May 20, 2026
Accepted on: Jun 22, 2026
Published on: Aug 3, 2026
Published by: West Pomeranian University of Technology, Szczecin
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Related subjects:
© 2026 Sofiia Volosiuk, Sara Wasilewska, Karolina Wenelska, Elżbieta Czarniewska, Dariusz Wawrzyniak, Ewa Mijowska, published by West Pomeranian University of Technology, Szczecin
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.